CFTR modulator theratyping: Current status, gaps and future directionsJohn P. Clancy, Katherine L. Tuggle, Donald R. VanDevanter et al.|Journal of Cystic Fibrosis|2018Cited by 288
Organoids as a personalized medicine tool for ultra-rare mutations in cystic fibrosis: The case of S955P and 1717-2A>GIris A. L. Silva, Margarida D. Amaral, Tereza Doušová et al.|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2020Cited by 13